e-learning
resources
Berlin 2008
Monday, 06.10.2008
Mechanisms of respiratory infections: interaction between the pathogen and the host
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
High prevalence of gramnegative enteric bacilli and pseudomonas in mild exacerbation of early stages COPD (Gold I-II)
J. Padua, A. Ramirez-Venegas, R. J. Hernandez-Zenteno, C. Sanchez-Romero, F. Quinones-Falconi, R. H. Sansores-Martinez (Mexico City/DF, Mexico)
Source:
Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host
Session:
Mechanisms of respiratory infections: interaction between the pathogen and the host
Session type:
Thematic Poster Session
Number:
2300
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Padua, A. Ramirez-Venegas, R. J. Hernandez-Zenteno, C. Sanchez-Romero, F. Quinones-Falconi, R. H. Sansores-Martinez (Mexico City/DF, Mexico). High prevalence of gramnegative enteric bacilli and pseudomonas in mild exacerbation of early stages COPD (Gold I-II). Eur Respir J 2008; 32: Suppl. 52, 2300
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
High mortality in COPD patients with isolation of
aspergillus spp
in bronchial secretions
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
Low blood eosinophil count is associated with gram-positive cocci infection and poor clinical outcomes in severe exacerbations of COPD
Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases
Year: 2020
Antimicrobial profile and bacterial resistance in patients wit acute exacerbation of COPD, an Upper Egypt multicenters experience
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013
Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study
Source: Eur Respir J 2013; 41: 1107-1115
Year: 2013
Evolution of antimicrobial susceptibility of respiratory isolates in chronic obstructive pulmonary patients diagnosed of acquired community pneumonia
Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants
Year: 2015
Influence of biofim on the bronchial microbiome in COPD patients colonized or infected by pseudomonas aeruginosa
Source: International Congress 2015 – Advances from translational research in respiratory infections
Year: 2015
Robustness of assessment of pulmonary endpoints in phase 3 trials with ARD-3150 in non-cystic fibrosis bronchiectasis (NCFB) patients with chronic Pseudomonas aeruginosa (PA) infections
Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis
Year: 2018
Pseudomonas aeruginosa in patients hospitalised for COPD exacerbation: a prospective study
Source: Eur Respir J 2009; 34: 1072-1078
Year: 2009
The impact of pseudomonas aeruginosa in the sputum of patients presenting with acute COPD exacerbation
Source: Annual Congress 2004 - Role of infection in COPD
Year: 2004
Severe exacerbations of chronic obstructive pulmonary disease (COPD) due to
Pseudomonas aeruginosa
: resistance to common antibiotics
Source: Eur Respir J 2001; 18: Suppl. 33, 540s
Year: 2001
Acute exacerbations of COPD due to pseudomonas aeruginosa: Impact of antimicrobial resistance
Source: International Congress 2015 – Infection in COPD: different aspects of the host/pathogen balance
Year: 2015
The role of atypical respiratory pathogens in exacerbations of chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 30: 240-244
Year: 2007
Common and atypical pathogens in severe COPD exacerbations and predictors of positive sputum cultures
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010
Telithromycin displays high clinical efficacy in outpatients with mild to moderate community-acquired pneumonia caused by atypical/intracellular pathogens
Source: Eur Respir J 2003; 22: Suppl. 45, 151s
Year: 2003
Enhanced neutrophil response in patients with chronic bronchitis and community-acquired pneumonia (CAP)
Source: Eur Respir J 2002; 20: Suppl. 38, 418s
Year: 2002
Antibacterial activity of telithromycin (TEL) and comparators against bacterial pathogens isolated from patients with acute exacerbations of chronic bronchitis (AECB) in the PROTEKT study 1999–2002
Source: Eur Respir J 2004; 24: Suppl. 48, 641s
Year: 2004
Serum procalcitonin (PCT-Q) as a diagnostic tool for bacterial lower respiratory tract infection among COPD patients with acute exacerbation
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
Etiology of exacerbations in severe COPD patients with bronchial chronic colonization by pseudomonas
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
Bacterial infections in patients with acute exacerbations of COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 639s
Year: 2004
Disseminated bacterial community-acquired pneumonia in patients at late stages of HIV infection
Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept